M. Murakami et al., THERAPEUTIC EFFECTS OF LANSOPRAZOLE ON PEPTIC-ULCERS IN ELDERLY PATIENTS, Journal of clinical gastroenterology, 20, 1995, pp. 79-82
We studied the effects of lansoprazole on ulcer healing and Helicobact
er pylori infection in elderly patients with peptic ulcers, In a group
of 24 patients with gastric ulcers, the H. pylori infection rate was
100%. In the course of gastric ulcer healing with famotidine or lansop
razole alone, the H. pylori infection showed no signs of decline. The
deer healing rates after 8 weeks were similar between the H-2-receptor
antagonist famotidine (73%), and the proton pump inhibitor lansoprazo
le (82%). When eradication of H. pylori infection was attempted by con
comitant administration of lansoprazole and amoxicillin 500 mg b.i.d.
for 2 weeks, the eradication rate was 33% in the group given lansopraz
ole 30 mg q.d. plus ampicillin 500 mg b.i.d., whereas it was 77% in th
e group given lansoprazole 30 mg b.i.d. plus ampicillin 500 mg b.i.d.
Lansoprazole is considered to be a useful agent for the treatment of p
atients with peptic ulcers and H. pylori infection and its effectivene
ss in H. pylori eradication is improved by b.i.d. administration along
with ampicillin.